カテゴリー： QYResearch, 世界

世界の商用バイオマーカー市場 2019年

【英語タイトル】Global Commercializing Biomarkers Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X05793）・商品コード：DATA909X05793
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、商用バイオマーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、消耗品、サービス、ソフトウェアに、用途別には、腫瘍学、心臓病学、神経学、その他にセグメント区分し、商用バイオマーカーの世界市場を分析しました。


・エグゼクティブ・サマリー
・商用バイオマーカーの世界市場概要
・商用バイオマーカーの製造コスト構成分析
・商用バイオマーカーの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・商用バイオマーカーの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・商用バイオマーカーのセグメント分析（種類別）
（消耗品、サービス、ソフトウェア）
・商用バイオマーカーのセグメント分析（用途別）
（腫瘍学、心臓病学、神経学、その他）
・商用バイオマーカーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Roche、Dako (Agilent Technologies)、Merck、BD、Abbott、Genesys Biolabs (20/20GeneSystems)、Affymetrix、Agendia、ALMAC、Arrayit、Biocartic、BG Medicine、KEGG EXPRESSION Database、Thermo Fisher、BGI、）
・商用バイオマーカーの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Commercializing Biomarkers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Commercializing Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Commercializing Biomarkers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Commercializing Biomarkers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Commercializing Biomarkers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Consumables
Services
Software

Segment by Application
Oncology
Cardiology
Neurology
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Commercializing Biomarkers
1.1 Definition of Commercializing Biomarkers
1.2 Commercializing Biomarkers Segment by Type
1.2.1 Global Commercializing Biomarkers Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Consumables
1.2.3 Services
1.2.4 Software
1.3 Commercializing Biomarkers Segment by Applications
1.3.1 Global Commercializing Biomarkers Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Global Commercializing Biomarkers Overall Market
1.4.1 Global Commercializing Biomarkers Revenue (2014-2025)
1.4.2 Global Commercializing Biomarkers Production (2014-2025)
1.4.3 North America Commercializing Biomarkers Status and Prospect (2014-2025)
1.4.4 Europe Commercializing Biomarkers Status and Prospect (2014-2025)
1.4.5 China Commercializing Biomarkers Status and Prospect (2014-2025)
1.4.6 Japan Commercializing Biomarkers Status and Prospect (2014-2025)
1.4.7 Southeast Asia Commercializing Biomarkers Status and Prospect (2014-2025)
1.4.8 India Commercializing Biomarkers Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers
2.3 Manufacturing Process Analysis of Commercializing Biomarkers
2.4 Industry Chain Structure of Commercializing Biomarkers

3 Development and Manufacturing Plants Analysis of Commercializing Biomarkers
3.1 Capacity and Commercial Production Date
3.2 Global Commercializing Biomarkers Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Commercializing Biomarkers
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Commercializing Biomarkers Production and Capacity Analysis
4.2 Commercializing Biomarkers Revenue Analysis
4.3 Commercializing Biomarkers Price Analysis
4.4 Market Concentration Degree

5 Commercializing Biomarkers Regional Market Analysis
5.1 Commercializing Biomarkers Production by Regions
5.1.1 Global Commercializing Biomarkers Production by Regions
5.1.2 Global Commercializing Biomarkers Revenue by Regions
5.2 Commercializing Biomarkers Consumption by Regions
5.3 North America Commercializing Biomarkers Market Analysis
5.3.1 North America Commercializing Biomarkers Production
5.3.2 North America Commercializing Biomarkers Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Commercializing Biomarkers Import and Export
5.4 Europe Commercializing Biomarkers Market Analysis
5.4.1 Europe Commercializing Biomarkers Production
5.4.2 Europe Commercializing Biomarkers Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Commercializing Biomarkers Import and Export
5.5 China Commercializing Biomarkers Market Analysis
5.5.1 China Commercializing Biomarkers Production
5.5.2 China Commercializing Biomarkers Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Commercializing Biomarkers Import and Export
5.6 Japan Commercializing Biomarkers Market Analysis
5.6.1 Japan Commercializing Biomarkers Production
5.6.2 Japan Commercializing Biomarkers Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Commercializing Biomarkers Import and Export
5.7 Southeast Asia Commercializing Biomarkers Market Analysis
5.7.1 Southeast Asia Commercializing Biomarkers Production
5.7.2 Southeast Asia Commercializing Biomarkers Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Commercializing Biomarkers Import and Export
5.8 India Commercializing Biomarkers Market Analysis
5.8.1 India Commercializing Biomarkers Production
5.8.2 India Commercializing Biomarkers Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Commercializing Biomarkers Import and Export

6 Commercializing Biomarkers Segment Market Analysis (by Type)
6.1 Global Commercializing Biomarkers Production by Type
6.2 Global Commercializing Biomarkers Revenue by Type
6.3 Commercializing Biomarkers Price by Type

7 Commercializing Biomarkers Segment Market Analysis (by Application)
7.1 Global Commercializing Biomarkers Consumption by Application
7.2 Global Commercializing Biomarkers Consumption Market Share by Application (2014-2019)

8 Commercializing Biomarkers Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Commercializing Biomarkers Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Dako (Agilent Technologies)
8.2.1 Dako (Agilent Technologies) Commercializing Biomarkers Production Sites and Area Served
8.2.2 Dako (Agilent Technologies) Product Introduction, Application and Specification
8.2.3 Dako (Agilent Technologies) Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Commercializing Biomarkers Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BD
8.4.1 BD Commercializing Biomarkers Production Sites and Area Served
8.4.2 BD Product Introduction, Application and Specification
8.4.3 BD Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Abbott
8.5.1 Abbott Commercializing Biomarkers Production Sites and Area Served
8.5.2 Abbott Product Introduction, Application and Specification
8.5.3 Abbott Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Genesys Biolabs (20/20GeneSystems)
8.6.1 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production Sites and Area Served
8.6.2 Genesys Biolabs (20/20GeneSystems) Product Introduction, Application and Specification
8.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Affymetrix
8.7.1 Affymetrix Commercializing Biomarkers Production Sites and Area Served
8.7.2 Affymetrix Product Introduction, Application and Specification
8.7.3 Affymetrix Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Agendia
8.8.1 Agendia Commercializing Biomarkers Production Sites and Area Served
8.8.2 Agendia Product Introduction, Application and Specification
8.8.3 Agendia Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 ALMAC
8.9.1 ALMAC Commercializing Biomarkers Production Sites and Area Served
8.9.2 ALMAC Product Introduction, Application and Specification
8.9.3 ALMAC Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Arrayit
8.10.1 Arrayit Commercializing Biomarkers Production Sites and Area Served
8.10.2 Arrayit Product Introduction, Application and Specification
8.10.3 Arrayit Commercializing Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Biocartic
8.12 BG Medicine
8.13 KEGG EXPRESSION Database
8.14 Thermo Fisher
8.15 BGI

9 Development Trend of Analysis of Commercializing Biomarkers Market
9.1 Global Commercializing Biomarkers Market Trend Analysis
9.1.1 Global Commercializing Biomarkers Market Size (Volume and Value) Forecast 2019-2025
9.2 Commercializing Biomarkers Regional Market Trend
9.2.1 North America Commercializing Biomarkers Forecast 2019-2025
9.2.2 Europe Commercializing Biomarkers Forecast 2019-2025
9.2.3 China Commercializing Biomarkers Forecast 2019-2025
9.2.4 Japan Commercializing Biomarkers Forecast 2019-2025
9.2.5 Southeast Asia Commercializing Biomarkers Forecast 2019-2025
9.2.6 India Commercializing Biomarkers Forecast 2019-2025
9.3 Commercializing Biomarkers Market Trend (Product Type)
9.4 Commercializing Biomarkers Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Commercializing Biomarkers Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Commercializing Biomarkers
Table Global Commercializing Biomarkers Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Commercializing Biomarkers Production Market Share by Types in 2018
Figure Consumables Product Picture
Figure Services Product Picture
Figure Software Product Picture
Table Global Commercializing Biomarkers Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Commercializing Biomarkers Consumption Market Share by Applications in 2018
Figure Oncology
Figure Cardiology
Figure Neurology
Figure Others
Figure Global Commercializing Biomarkers Revenue (Million USD) (2014-2025)
Figure Global Commercializing Biomarkers Production (K Units) (2014-2025)
Figure North America Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Figure Europe Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Figure China Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Figure Japan Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Figure Southeast Asia Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Figure India Commercializing Biomarkers Market Size (Million USD) (2014-2025)
Table Commercializing Biomarkers Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Commercializing Biomarkers in 2018
Figure Manufacturing Process Analysis of Commercializing Biomarkers
Figure Industry Chain Structure of Commercializing Biomarkers
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Commercializing Biomarkers Manufacturing Plants Distribution
Table Commercializing Biomarkers Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Commercializing Biomarkers Capacity (K Units) of Major Manufacturers (2014-2019)
Table Commercializing Biomarkers Production (K Units) of Major Manufacturers (2014-2019)
Table Commercializing Biomarkers Production Market Share of Major Manufacturers (2014-2019)
Figure Commercializing Biomarkers Production Share by Manufacturers in 2018
Table Commercializing Biomarkers Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Commercializing Biomarkers Revenue Market Share of Major Manufacturers (2014-2019)
Figure Commercializing Biomarkers Revenue Share by Manufacturers in 2018
Table Commercializing Biomarkers Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Commercializing Biomarkers Production by Regions 2014-2019 (K Units)
Table Global Commercializing Biomarkers Production Market Share by Regions 2014-2019
Figure Global Commercializing Biomarkers Production Market Share by Regions in 2018
Table Global Commercializing Biomarkers Revenue by Regions 2014-2019 (Million USD)
Table Global Commercializing Biomarkers Revenue Market Share by Regions 2014-2019
Figure Global Commercializing Biomarkers Revenue Market Share by Regions in 2018
Table Global Commercializing Biomarkers Consumption by Regions 2014-2019 (K Units)
Table Global Commercializing Biomarkers Consumption Market Share by Regions 2014-2019
Figure North America Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure North America Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table North America Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure Europe Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Europe Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure China Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure China Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table China Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure Japan Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Japan Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure Southeast Asia Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure India Commercializing Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure India Commercializing Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table India Commercializing Biomarkers Production, Consumption Import and Export (K Units)
Figure Global Consumption Commercializing Biomarkers Market Share by Application (2014-2019)
Figure Global Value (Consumption) Commercializing Biomarkers Market Share by Application (2014-2019)
Table Roche Commercializing Biomarkers Production Sites and Area Served
Table Roche Commercializing Biomarkers Product Introduction, Application and Specification
Table Roche Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Roche Commercializing Biomarkers Production Market Share (2014-2019)
Figure Roche Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Roche Commercializing Biomarkers Main Business and Markets Served
Table Dako (Agilent Technologies) Commercializing Biomarkers Production Sites and Area Served
Table Dako (Agilent Technologies) Commercializing Biomarkers Product Introduction, Application and Specification
Table Dako (Agilent Technologies) Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dako (Agilent Technologies) Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Dako (Agilent Technologies) Commercializing Biomarkers Production Market Share (2014-2019)
Figure Dako (Agilent Technologies) Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Dako (Agilent Technologies) Commercializing Biomarkers Main Business and Markets Served
Table Merck Commercializing Biomarkers Production Sites and Area Served
Table Merck Commercializing Biomarkers Product Introduction, Application and Specification
Table Merck Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Merck Commercializing Biomarkers Production Market Share (2014-2019)
Figure Merck Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Merck Commercializing Biomarkers Main Business and Markets Served
Table BD Commercializing Biomarkers Production Sites and Area Served
Table BD Commercializing Biomarkers Product Introduction, Application and Specification
Table BD Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BD Commercializing Biomarkers Production Growth Rate (2014-2019)
Table BD Commercializing Biomarkers Production Market Share (2014-2019)
Figure BD Commercializing Biomarkers Revenue Market Share (2014-2019)
Table BD Commercializing Biomarkers Main Business and Markets Served
Table Abbott Commercializing Biomarkers Production Sites and Area Served
Table Abbott Commercializing Biomarkers Product Introduction, Application and Specification
Table Abbott Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Abbott Commercializing Biomarkers Production Market Share (2014-2019)
Figure Abbott Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Abbott Commercializing Biomarkers Main Business and Markets Served
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production Sites and Area Served
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Product Introduction, Application and Specification
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Production Market Share (2014-2019)
Figure Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Main Business and Markets Served
Table Affymetrix Commercializing Biomarkers Production Sites and Area Served
Table Affymetrix Commercializing Biomarkers Product Introduction, Application and Specification
Table Affymetrix Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Affymetrix Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Affymetrix Commercializing Biomarkers Production Market Share (2014-2019)
Figure Affymetrix Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Affymetrix Commercializing Biomarkers Main Business and Markets Served
Table Agendia Commercializing Biomarkers Production Sites and Area Served
Table Agendia Commercializing Biomarkers Product Introduction, Application and Specification
Table Agendia Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Agendia Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Agendia Commercializing Biomarkers Production Market Share (2014-2019)
Figure Agendia Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Agendia Commercializing Biomarkers Main Business and Markets Served
Table ALMAC Commercializing Biomarkers Production Sites and Area Served
Table ALMAC Commercializing Biomarkers Product Introduction, Application and Specification
Table ALMAC Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ALMAC Commercializing Biomarkers Production Growth Rate (2014-2019)
Table ALMAC Commercializing Biomarkers Production Market Share (2014-2019)
Figure ALMAC Commercializing Biomarkers Revenue Market Share (2014-2019)
Table ALMAC Commercializing Biomarkers Main Business and Markets Served
Table Arrayit Commercializing Biomarkers Production Sites and Area Served
Table Arrayit Commercializing Biomarkers Product Introduction, Application and Specification
Table Arrayit Commercializing Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Arrayit Commercializing Biomarkers Production Growth Rate (2014-2019)
Table Arrayit Commercializing Biomarkers Production Market Share (2014-2019)
Figure Arrayit Commercializing Biomarkers Revenue Market Share (2014-2019)
Table Arrayit Commercializing Biomarkers Main Business and Markets Served
Table Biocartic Commercializing Biomarkers Production Sites and Area Served
Table BG Medicine Commercializing Biomarkers Production Sites and Area Served
Table KEGG EXPRESSION Database Commercializing Biomarkers Production Sites and Area Served
Table Thermo Fisher Commercializing Biomarkers Production Sites and Area Served
Table BGI Commercializing Biomarkers Production Sites and Area Served
Figure Global Commercializing Biomarkers Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Commercializing Biomarkers Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Commercializing Biomarkers Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Commercializing Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Commercializing Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Commercializing Biomarkers by Type (2019-2025)
Table Global Consumption (K Units) of Commercializing Biomarkers by Application (2019-2025)
Table Commercializing Biomarkers Distributors List
Table Commercializing Biomarkers Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、Dako (Agilent Technologies)、Merck、BD、Abbott、Genesys Biolabs (20/20GeneSystems)、Affymetrix、Agendia、ALMAC、Arrayit、Biocartic、BG Medicine、KEGG EXPRESSION Database、Thermo Fisher、BGI、

★調査レポート[世界の商用バイオマーカー市場 2019年] (コード：DATA909X05793)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の商用バイオマーカー市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のNASH（非アルコール性脂肪性肝炎）バイオマーカー市場 2019年
    DATA909X11853 / QYResearch / 2019年11月20日 / ※本調査レポートは、NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他に、用途別には、製薬＆CRO産業、病院、診断ラボ、学術研究所にセグメント区分し、NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場概要 ・NASH（非アルコール性脂肪性肝炎）バイオマーカーの製造コスト構成分析 ・NASH（非アルコール性脂肪性肝炎）バイオマーカーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・NASH（非アルコール性脂肪性肝炎）バイオマーカーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・NASH（非アルコール性脂肪性肝炎）バイオマーカーのセグメント分析（種類別） （血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他）...The global NASH (Non-alcoholic Steatohepatitis) Biomarkers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on NASH (Non-alcoholic Steatohepatitis) Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall NASH (Non-alcoholic Steatohepatitis) Biomarkers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of NASH (Non-alcoholic Steatohepatitis) Biomarkers in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の外傷性脳損傷治療薬市場 2019年
    DATA909X16800 / QYResearch / 2019年11月22日 / ※本調査レポートは、外傷性脳損傷治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アセチルコリンエステラーゼ阻害剤、エリスロポエチン、成長ホルモン、幹細胞、その他に、用途別には、焦点TBI、オープンTBI、クローズTBI、拡散TBI、プライマリTBI、その他にセグメント区分し、外傷性脳損傷治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・外傷性脳損傷治療薬の世界市場概要 ・外傷性脳損傷治療薬の製造コスト構成分析 ・外傷性脳損傷治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・外傷性脳損傷治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・外傷性脳損傷治療薬のセグメント分析（種類別） （アセチルコリンエステラーゼ阻害剤、エリスロポエチン、成長ホルモン、幹細胞、その他）...The global Traumatic Brain Injury Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Traumatic Brain Injury Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Traumatic Brain Injury Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Traumatic Brain Injury Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 外傷性脳損傷診断の世界市場：規模・現状・予測2019-2025
    DATA909X19050 / QYResearch / 2019年11月25日 / ※当調査レポートでは、外傷性脳損傷診断の世界市場について調査・分析し、外傷性脳損傷診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（）、用途別（）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の外傷性脳損傷診断市場動向 ・主要企業別マーケットシェア ・外傷性脳損傷診断の種類別市場規模2014-2019 （） ・外傷性脳損傷診断の用途別市場規模2014-2019 （） ・外傷性脳損傷診断の北米市場：主要企業・種類別/用途別市場規模 ・外傷性脳損傷診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...The global Traumatic Brain Injury Diagnostic Market Size will reach 161.86 million US$ in 2025, from 37.51 million US$ in 2018, with a CAGR of 23.10% during the forecast period. This report focuses on the global Traumatic Brain Injury Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Traumatic Brain Injury Diagnostic development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions The key players covered in this study Banyan Biomarkers ImPACT Application BrainScope InfraScan BrainBox Solution Quanterix BioDirection ABCDx Oculogica Market segment by...

    • ◆H&Iグローバルリサーチのお客様（例）◆